Skip to main content
. 2019 Jan 24;23(4):2384–2398. doi: 10.1111/jcmm.14043

Table 1.

Univariate and multivariate analysis of factors associated with survival and recurrence

Variables Overall survival Relapse‐free survival
Univariate
P value
Multivariate Univariate
P value
Multivariate
HR (95% CI) p value HR (95% CI) p value
Age, y (>52 vs ≤52) 0.479 NA 0.513 NA
Gender (male vs female) 0.591 NA 0.671 NA
HBsAg (positive vs negative) 0.600 NA 0.482 NA
Liver cirrhosis (yes vs no) 0.920 NA 0.383 NA
HCC family history (yes vs no) 0.101 NA 0.091 NA
AFP, ng/mL (>20 vs ≤20) 0.004 1.55 (1.04‐2.30) 0.030 0.002 1.76 (1.14‐2.71) 0.010
ALT, U/L (>75 vs ≤75) 0.169 NA 0.050 NA
γ‐GT, U/L (>54 vs ≤54) <0.001 1.74 (1.17‐2.67) 0.006 <0.001 1.80 (1.15‐2.80) 0.009
Tumour size (>5 vs ≤5) <0.001 1.96 (1.33‐2.91) 0.001 <0.001 1.91 (1.24‐2.94) 0.003
Tumour number (multiple vs single) 0.195 NA 0.133 NA
Tumour capsule (yes vs no) 0.046 NS 0.055 NA
Tumour differentiation (III‐IV vs I‐II) 0.004 NS 0.002 NS
Vascular invasion (Yes vs No) <0.001 1.86 (1.27‐2.72) 0.001 <0.001 1.71 (1.12‐2.61) 0.013
EIF4E (high vs low) 0.021 NS 0.002 1.67 (1.13‐2.45) 0.010

Univariate analysis was calculated by the Kaplan‐Meier method (log‐rank test). Multivariate analysis was done using the Cox multivariate proportional hazard regression model with stepwise manner (forward, likelihood ratio).

CI, confidential interval; HR, hazard ratio; NA, not adopted; NS, not significant.